Caveolin-1 and Vascular Dysfunction

计划入组 120 人 · 首次发布于 2011 年 8 月 31 日

Role of Urinary Claudin-2, Caveolin-1, and EGF as Diagnostic Biomarkers of Necrotizing Enterocolitis in Preterm Neonates

计划入组 30 人 · 首次发布于 2022 年 4 月 19 日

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

计划入组 30 人 · 首次发布于 2023 年 10 月 6 日

LTI-03

SynCav1

Goserelin(Zoladex)

C₅₉H₈₄N₁₈O₁₄ · Rx

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Systemic Gene Therapy SynCav1 Shields Brain from TDP-43 Damage by Fortifying Neuronal Resilience

Aileron Therapeutics Rebrands as Rein Therapeutics, Focuses on Fibrosis Therapies

Aileron Therapeutics Presents Positive Phase 1b Data for LTI-03 in Idiopathic Pulmonary Fibrosis